Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/75894
Title: Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting
Authors: Cher Heng Tan
Shu Cheng Chou
Nakarin Inmutto
Ke Ma
Ruofan Sheng
Yinghong Shi
Zhongguo Zhou
Akira Yamada
Ryosuke Tateishi
Authors: Cher Heng Tan
Shu Cheng Chou
Nakarin Inmutto
Ke Ma
Ruofan Sheng
Yinghong Shi
Zhongguo Zhou
Akira Yamada
Ryosuke Tateishi
Keywords: Medicine
Issue Date: 1-Jul-2022
Abstract: Gadoxetate magnetic resonance imaging (MRI) is widely used in clinical practice for liver imaging. For optimal use, we must understand both its advantages and limitations. This article is the outcome of an online advisory board meeting and subsequent discussions by a multidisciplinary group of experts on liver diseases across the Asia-Pacific region, first held on September 28, 2020. Here, we review the technical considerations for the use of gadoxetate, its current role in the management of patients with hepatocellular carcinoma (HCC), and its relevance in consensus guidelines for HCC imaging diagnosis. In the latter part of this review, we examine recent evidence evaluating the impact of gadoxetate on clinical outcomes on a continuum from diagnosis to treatment decision-making and follow-up. In conclusion, we outline the potential future roles of gadoxetate MRI based on an evolving understanding of the clinical utility of this contrast agent in the management of patients at risk of, or with, HCC.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85133105275&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/75894
ISSN: 12296929
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.